Approaching a decade since HPV vaccine licensure: Racial and gender disparities in knowledge and awareness of HPV and HPV vaccine
| Autor: | Nosayaba Osazuwa-Peters, Betelihem B. Tobo, Christian J. Geneus, Rebecca P. Rojek, Kahee A. Mohammed, Eric Adjei Boakye |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Adult
Male Health Knowledge Attitudes Practice medicine.medical_specialty Immunology Ethnic group Logistic regression White People 03 medical and health sciences 0302 clinical medicine Surveys and Questionnaires 030225 pediatrics Ethnicity medicine Humans Immunology and Allergy Papillomavirus Vaccines 030212 general & internal medicine Healthcare Disparities Human papillomavirus Papillomaviridae Aged Pharmacology Gynecology Licensure business.industry Papillomavirus Infections Racial Groups Vaccination virus diseases Hpv vaccination Health Status Disparities Hispanic or Latino Middle Aged Patient Acceptance of Health Care United States female genital diseases and pregnancy complications Health Information National Trends Survey Black or African American Logistic Models Female business Hpv knowledge Research Paper Demography |
| Zdroj: | Human Vaccines & Immunotherapeutics. 13:2713-2722 |
| ISSN: | 2164-554X 2164-5515 |
| DOI: | 10.1080/21645515.2017.1363133 |
| Popis: | Purpose: Gaps remain in the public's knowledge of the human papillomavirus (HPV). We assessed racial/ethnic and gender disparities in knowledge and awareness of HPV and the HPV vaccine among US adults.Data from the Health Information National Trends Survey 4 Cycle 3 (September - December 2013) and Cycle 4 (August - November 2014) were analyzed for 6,862 respondents aged 18 years and older. Weighted multivariable logistic regression models were used to estimate racial/ethnic and gender disparities in HPV knowledge and HPV vaccination awareness.Sixty-six percent of respondents had heard of HPV and the HPV vaccine (57% of men vs. 75% of women). In multivariable analyses, compared with men, women were 225% (95% CI: 2.60 - 4.07) more likely to have heard of HPV, and 281% (95% CI: 3.06 - 4.74) more likely to have heard of the HPV vaccine. Non-Hispanic Blacks were 33% (95% CI: 0.47 - 0.96) and 44% (95% CI: 0.39 - 0.81) less likely than non-Hispanic Whites to have heard of HPV and the HPV vaccine, respectively. Hispanics were 27% (95% CI: 0.52 - 1.02) and 53% (95% CI: 0.34 - 0.64) less likely than non-Hispanic Whites to have heard of HPV and the HPV vaccine, respectively.There was evidence of disparities in HPV and HPV vaccine awareness among men compared with women and non-Hispanic Blacks and Hispanics compared with non-Hispanic Whites. To foster improvements in HPV vaccine uptake and reduce disparities in HPV associated cancers, future interventions must target men and minority populations, for whom knowledge gaps exist. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|